2022
DOI: 10.1080/15548627.2022.2047343
|View full text |Cite
|
Sign up to set email alerts
|

Targeting lipophagy in macrophages improves repair in multiple sclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 26 publications
(14 citation statements)
references
References 62 publications
0
9
0
Order By: Relevance
“…Additionally, the upregulation of pathways related to Antigen presentation, Interferon signaling , and Interleukin-2 signaling underscores the involvement of immune regulatory mechanisms in the pathogenesis, hinting at potential autoimmune components in MS [16]. Moreover, Lipophagy and Endosomal/vacuolar pathways point towards potential disruptions in cellular metabolism and intracellular trafficking processes [17]. The heightened activity in pathways associated with DNA damage response and senescence , as well as regulation of Heat shock response , suggests potential cellular stress and adaptive responses [18].…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, the upregulation of pathways related to Antigen presentation, Interferon signaling , and Interleukin-2 signaling underscores the involvement of immune regulatory mechanisms in the pathogenesis, hinting at potential autoimmune components in MS [16]. Moreover, Lipophagy and Endosomal/vacuolar pathways point towards potential disruptions in cellular metabolism and intracellular trafficking processes [17]. The heightened activity in pathways associated with DNA damage response and senescence , as well as regulation of Heat shock response , suggests potential cellular stress and adaptive responses [18].…”
Section: Discussionmentioning
confidence: 99%
“…However, as the disease progresses, there is a shift toward M2-type macrophages taking over ( 47 , 49 ) ( Figure 3 ). It is known that taking myelin reduces inflammation and encourages the development of anti-inflammatory macrophages, demyelination is a significant inflammatory component of MS and EAE, and macrophages have a direct impact on it by removing myelin from the myelin sheath by phagocytosis ( 50 , 51 ). Additionally, the blood-brain barrier’s (BBB) destruction is a significant contributor to neurological diseases, BBB can block the entry of harmful compounds into the CNS under normal physiological circumstances, whereas immune cells can pass through BBB ( 52 ).…”
Section: Autoimmune Diseasementioning
confidence: 99%
“…Additionally, the disease-mediated peroxisome injury in BAMs, leading to demyelination and axonal loss, may be prevented through treatment with 4-Phenylbutyrate, which serves as a potential therapeutic approach for halting inflammatory demyelination and the progression of MS [113]. Lastly, foamy macrophages are formed in brain regions during MS; by targeting lipophagy, remyelination can be promoted as some BAM subtypes may be involved in the aforementioned process [114,115].…”
Section: Bams In Multiple Sclerosismentioning
confidence: 99%